514-515 / 1778
Treatment characteristics
Treatment characteristics RT alone CTRT
Type of surgery (%)
TAH or TLH / BSO
TH/BSO plus LND
41.8%
58.2%
42.4%
57.6%
RT completion(%)
EBRT
BT boost (cervical invasion)
98.5%
47.9%
99.7%
45.8%
CT completion (%)
2 cisplatin
4 carboplatin-paclitaxel
-
-
92%
79%-71%
De Boer et al. Lancet Oncol 2018